These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 10682303

  • 1. Brain phenylalanine concentration in the management of adults with phenylketonuria.
    Moats RA, Koch R, Moseley K, Guldberg P, Guttler F, Boles RG, Nelson MD.
    J Inherit Metab Dis; 2000 Feb; 23(1):7-14. PubMed ID: 10682303
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.
    Leuzzi V, Bianchi MC, Tosetti M, Carducci CL, Carducci CA, Antonozzi I.
    J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331
    [Abstract] [Full Text] [Related]

  • 3. Blood-brain phenylalanine relationships in persons with phenylketonuria.
    Koch R, Moats R, Guttler F, Guldberg P, Nelson M.
    Pediatrics; 2000 Nov; 106(5):1093-6. PubMed ID: 11061780
    [Abstract] [Full Text] [Related]

  • 4. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K, Okano Y, Nakayama K, Hase Y, Minamikawa S, Ozawa N, Yokote H, Inoue Y.
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. White matter abnormalities in phenylketonuria: results of magnetic resonance measurements.
    Ullrich K, Möller H, Weglage J, Schuierer G, Bick U, Ludolph A, Hahn-Ullrich H, Fünders B, Koch HG.
    Acta Paediatr Suppl; 1994 Dec; 407():78-82. PubMed ID: 7766966
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change.
    Cleary MA, Walter JH, Wraith JE, White F, Tyler K, Jenkins JP.
    J Pediatr; 1995 Aug; 127(2):251-5. PubMed ID: 7636650
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.
    Mastrangelo M, Chiarotti F, Berillo L, Caputi C, Carducci C, Di Biasi C, Manti F, Nardecchia F, Leuzzi V.
    Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467
    [Abstract] [Full Text] [Related]

  • 16. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J, Ullrich K, Pietsch M, Fünders B, Güttler F, Harms E.
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.